Orchard Therapeutics Stock Forecast

Orchard therapeutics stock forecast Close price at the end of the last trading day (tuesday, 16th nov 2021) of the ortx stock was $1.58. 4 wall street analysts have issued ratings and price targets for orchard therapeutics in the last 12 months. On average, they anticipate orchard therapeutics' share price to reach $12.75 in the next twelve months. As of 2021 november 25,. A rank of 39 means that 61% of stocks appear more favorable to our system. Based on 5 wall street analysts offering 12 month price targets for orchard therapeutics in the last 3 months. The company listed on the u.s. During the day the stock fluctuated 7.50% from a day low at $1.20 to a day high of $1.29. Close price at the end of the last trading day (thursday, 2nd dec 2021) of the ortx stock was $1.28. The average price target is $13.33 with a high forecast of $15.00 and a low forecast of $12.00.

Orchard Therapeutics Plc Ortx Stock Volume - Impact On Prices

During the day the stock fluctuated 11.58% from a day low at $1.51 to a day high of $1.69. Get the latest orchard therapeutics stock price and detailed information including ortx news, historical charts and realtime prices. Their forecasts range from $12.00 to $14.00. The highest, average, and lowest price target of all. Orchard therapeutics plc adr is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The average price target represents a 896.09% upside from the last price of $1.28.

Orchard therapeutics stock forecast. Stock markets in 2018 and. This is 10.73% less than the trading day before monday, 15th nov 2021. On average, wall street analysts predict that. The average price target is $12.75, with a high forecast of $14.00 and a low forecast of $12.00. Orchard stock forecast is based on your current time horizon. Orchard therapeutics's share price could stay at $14.00 by nov 16, 2022. The average price target represents a 382.97% change from the last price of $2.76. Further, orchard therapeutics plc (ortx) has a beta value of 0, and an average true range (atr) of 0.11. Wall street stock market & finance report, prediction for the future: Investorsobserver gives orchard therapeutics plc adr (ortx) an overall rank of 39, which is below average. The average orchard therapeutics stock price prediction forecasts a potential downside of n/a from the current ortx share price of $1.21. Stock was originally listed at a price of $14.00 in oct 31, 2018. This chart shows the closing price for ortx. 30 rows about the orchard therapeutics plc stock forecast. According to 10 analysts, the average rating for ortx stock is strong. This price target is based on 4 analysts offering 12 month price targets for orchard therapeutics in the last 3 months. There are currently 4 buy ratings for. This suggests a possible upside of 953.7% from the stock's current price. There are few to no technical positive signals at the moment. This is 0.79% more than the trading day before wednesday, 1st dec 2021. The price to earnings (p/e) ratio, a key valuation measure, is calculated by. However, solely looking at the historical price movement is usually misleading. According to the issued ratings of 4 analysts in the last year, the consensus rating for orchard therapeutics stock is buy based on the current 1 sell rating and 3 buy ratings for ortx.

The high price target for ortx is $16.00 and the low price target for ortx is $12.00. Find the latest orchard therapeutics plc (ortx) stock quote, history, news and other vital information to help you with your stock trading and investing. News orchard therapeutics plc adrortx. No news for in the past two years.

Orchard Therapeutics Plc Ortx Stock Price Us68570p1012 Marketscreener

Orchard Therapeutics Plc Price Ot1a Forecast With Price Charts

Is Orchard Therapeutics Nasdaqortx A Risky Investment

Orchard Therapeutics An Undervalued Stock With Upcoming Catalysts Nasdaqortx Seeking Alpha

2 Strong Buy Penny Stocks That Could Deliver Massive Returns Nasdaq

Our View On Orchard Therapeutics Nasdaqortx Seeking Alpha

Orchard Therapeutics Plc - Adr Shares Near 52-week Low - Market Mover Nasdaq

Ortx Stock Forecast Price Targets And Analysts Predictions - Tipranks